A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Clinical trial NCT02959151 · UNKNOWN
Trial details
- NCT number
- NCT02959151
- Sponsor
- Shanghai GeneChem Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.